Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease
Consortia: CMAI
Ali R, Babad J, Follenzi A, Gebe JA, Brehm MA, Nepom GT, Shultz LD, Greiner DL, DiLorenzo TP.
Immunology. 2016 Aug;148(4):339-51. doi: 10.1111/imm.12613. PMID: 27124592